Semaglutide for the management of diabesity: The real-world experience

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1954

Figures (1-3)

294

Tables (1-6)

338

Sum=2658

Publishing Process of This Article

Item

Count

Browse

Download

242

Sum=330

Sep 20, 2024 (publication date) through Apr 15, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Methodol. Sep 20, 2024; 14(3): 91832
Published online Sep 20, 2024. doi: 10.5662/wjm.v14.i3.91832

Full Size Figure Download Figure

Figure 3 Displays the mean reduction in daily insulin requirement after initiating semaglutide.

Citation: Alkhalifah M, Afsar H, Shams A, Blaibel D, Chandrabalan V, Pappachan JM. Semaglutide for the management of diabesity: The real-world experience. World J Methodol 2024; 14(3): 91832
URL: https://www.wjgnet.com/2222-0682/full/v14/i3/91832.htm
DOI: https://dx.doi.org/10.5662/wjm.v14.i3.91832